Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?
Identifieur interne : 003776 ( PubMed/Corpus ); précédent : 003775; suivant : 003777Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?
Auteurs : Atilla Soran ; Gina D'Angelo ; Mirsada Begovic ; Figen Ardic ; Ali Harlak ; H. Samuel Wieand ; Victor G. Vogel ; Ronald R. JohnsonSource :
- The breast journal [ 1075-122X ]
English descriptors
- KwdEn :
- MESH :
- adverse effects : Lymph Node Excision, Mastectomy.
- etiology : Lymphedema.
- pathology : Breast Neoplasms, Lymphedema.
- surgery : Breast Neoplasms.
- Axilla, Case-Control Studies, Female, Humans, Lymphatic Metastasis, Middle Aged, Risk Factors, Severity of Illness Index.
Abstract
According to the American Cancer Society, there are currently 2 million breast cancer (BC) survivors in the USA and 20% of them cope with lymphedema (LE). The primary aim of this study was to determine the predictive factors of BC-related LE. The secondary aim was to investigate the impact of predictors on the severity of LE. The study design was intended to be a 1:2 matched case-control study. Instead, we stratified on age (+/-10 years), radiation therapy (y/n), and type of operation (SM/MRM/MRM with tram). Patients who underwent BC surgery between 1990 and 2000 at UPMC Magee-Womens Hospital were reviewed for LE. Data were collected on 52 women with LE and 104 female controls. Logistic regression was utilized to assess the relationship between risk factors and LE. Ordinal logistic regression was performed to determine the association between risk factors and severity of LE. Severity was defined according to the volume difference between affected and unaffected limbs. Risk factors considered were occupation/hobby (hand use), TNM stage, number of dissected nodes, number of positive nodes, tumor size, infection, allergy, diabetes mellitus, hypertension, hypothyroidism, chronic obstructive pulmonary disease, and body mass index (BMI). LE was mild in 43 patients and was moderate/severe in nine patients. The level of hand use in the control group was categorized as low in 56 (54%), medium in 15 (14%), and high in 33 (32%) patients. The corresponding frequencies were 14 (33%), 6 (14%) and 23 (53%) for patients with mild LE and 3 (33%), 1 (11%), 5 (56%) for patients with moderate/severe LE (p < 0.05). Infection of the operated side arm was reported by two (2%) patients in the control group, 14 (33%) patients with mild LE and five (56%) patients with moderate/severe LE (p < 0.05). The mean BMI was 26.1 kg/m(2) (SD 4.9) for the control group, 29.0 kg/m(2) (SD 5.9) for the mild LE group and 30.9 kg/m(2) (SD 7.5) for patients with moderate/severe LE (p < 0.05). The results of this stratified case-control study demonstrated that the risk and severity of LE was statistically related to infection, BMI, and level of hand use.
DOI: 10.1111/j.1524-4741.2006.00342.x
PubMed: 17238983
Links to Exploration step
pubmed:17238983Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?</title><author><name sortKey="Soran, Atilla" sort="Soran, Atilla" uniqKey="Soran A" first="Atilla" last="Soran">Atilla Soran</name><affiliation><nlm:affiliation>Magee-Womens Hospital, Pittsburgh, Pennsylvania 15213, USA. asoran@magee.edu</nlm:affiliation></affiliation></author><author><name sortKey="D Angelo, Gina" sort="D Angelo, Gina" uniqKey="D Angelo G" first="Gina" last="D'Angelo">Gina D'Angelo</name></author><author><name sortKey="Begovic, Mirsada" sort="Begovic, Mirsada" uniqKey="Begovic M" first="Mirsada" last="Begovic">Mirsada Begovic</name></author><author><name sortKey="Ardic, Figen" sort="Ardic, Figen" uniqKey="Ardic F" first="Figen" last="Ardic">Figen Ardic</name></author><author><name sortKey="Harlak, Ali" sort="Harlak, Ali" uniqKey="Harlak A" first="Ali" last="Harlak">Ali Harlak</name></author><author><name sortKey="Samuel Wieand, H" sort="Samuel Wieand, H" uniqKey="Samuel Wieand H" first="H" last="Samuel Wieand">H. Samuel Wieand</name></author><author><name sortKey="Vogel, Victor G" sort="Vogel, Victor G" uniqKey="Vogel V" first="Victor G" last="Vogel">Victor G. Vogel</name></author><author><name sortKey="Johnson, Ronald R" sort="Johnson, Ronald R" uniqKey="Johnson R" first="Ronald R" last="Johnson">Ronald R. Johnson</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2006 Nov-Dec</MedlineDate></PubDate></date><idno type="RBID">pubmed:17238983</idno><idno type="pmid">17238983</idno><idno type="doi">10.1111/j.1524-4741.2006.00342.x</idno><idno type="wicri:Area/PubMed/Corpus">003776</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003776</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?</title><author><name sortKey="Soran, Atilla" sort="Soran, Atilla" uniqKey="Soran A" first="Atilla" last="Soran">Atilla Soran</name><affiliation><nlm:affiliation>Magee-Womens Hospital, Pittsburgh, Pennsylvania 15213, USA. asoran@magee.edu</nlm:affiliation></affiliation></author><author><name sortKey="D Angelo, Gina" sort="D Angelo, Gina" uniqKey="D Angelo G" first="Gina" last="D'Angelo">Gina D'Angelo</name></author><author><name sortKey="Begovic, Mirsada" sort="Begovic, Mirsada" uniqKey="Begovic M" first="Mirsada" last="Begovic">Mirsada Begovic</name></author><author><name sortKey="Ardic, Figen" sort="Ardic, Figen" uniqKey="Ardic F" first="Figen" last="Ardic">Figen Ardic</name></author><author><name sortKey="Harlak, Ali" sort="Harlak, Ali" uniqKey="Harlak A" first="Ali" last="Harlak">Ali Harlak</name></author><author><name sortKey="Samuel Wieand, H" sort="Samuel Wieand, H" uniqKey="Samuel Wieand H" first="H" last="Samuel Wieand">H. Samuel Wieand</name></author><author><name sortKey="Vogel, Victor G" sort="Vogel, Victor G" uniqKey="Vogel V" first="Victor G" last="Vogel">Victor G. Vogel</name></author><author><name sortKey="Johnson, Ronald R" sort="Johnson, Ronald R" uniqKey="Johnson R" first="Ronald R" last="Johnson">Ronald R. Johnson</name></author></analytic><series><title level="j">The breast journal</title><idno type="ISSN">1075-122X</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Axilla</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (surgery)</term><term>Case-Control Studies</term><term>Female</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymphatic Metastasis</term><term>Lymphedema (etiology)</term><term>Lymphedema (pathology)</term><term>Mastectomy (adverse effects)</term><term>Middle Aged</term><term>Risk Factors</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term><term>Mastectomy</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Axilla</term><term>Case-Control Studies</term><term>Female</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Risk Factors</term><term>Severity of Illness Index</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">According to the American Cancer Society, there are currently 2 million breast cancer (BC) survivors in the USA and 20% of them cope with lymphedema (LE). The primary aim of this study was to determine the predictive factors of BC-related LE. The secondary aim was to investigate the impact of predictors on the severity of LE. The study design was intended to be a 1:2 matched case-control study. Instead, we stratified on age (+/-10 years), radiation therapy (y/n), and type of operation (SM/MRM/MRM with tram). Patients who underwent BC surgery between 1990 and 2000 at UPMC Magee-Womens Hospital were reviewed for LE. Data were collected on 52 women with LE and 104 female controls. Logistic regression was utilized to assess the relationship between risk factors and LE. Ordinal logistic regression was performed to determine the association between risk factors and severity of LE. Severity was defined according to the volume difference between affected and unaffected limbs. Risk factors considered were occupation/hobby (hand use), TNM stage, number of dissected nodes, number of positive nodes, tumor size, infection, allergy, diabetes mellitus, hypertension, hypothyroidism, chronic obstructive pulmonary disease, and body mass index (BMI). LE was mild in 43 patients and was moderate/severe in nine patients. The level of hand use in the control group was categorized as low in 56 (54%), medium in 15 (14%), and high in 33 (32%) patients. The corresponding frequencies were 14 (33%), 6 (14%) and 23 (53%) for patients with mild LE and 3 (33%), 1 (11%), 5 (56%) for patients with moderate/severe LE (p < 0.05). Infection of the operated side arm was reported by two (2%) patients in the control group, 14 (33%) patients with mild LE and five (56%) patients with moderate/severe LE (p < 0.05). The mean BMI was 26.1 kg/m(2) (SD 4.9) for the control group, 29.0 kg/m(2) (SD 5.9) for the mild LE group and 30.9 kg/m(2) (SD 7.5) for patients with moderate/severe LE (p < 0.05). The results of this stratified case-control study demonstrated that the risk and severity of LE was statistically related to infection, BMI, and level of hand use.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17238983</PMID><DateCreated><Year>2007</Year><Month>01</Month><Day>22</Day></DateCreated><DateCompleted><Year>2007</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2007</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1075-122X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>6</Issue><PubDate><MedlineDate>2006 Nov-Dec</MedlineDate></PubDate></JournalIssue><Title>The breast journal</Title><ISOAbbreviation>Breast J</ISOAbbreviation></Journal><ArticleTitle>Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?</ArticleTitle><Pagination><MedlinePgn>536-43</MedlinePgn></Pagination><Abstract><AbstractText>According to the American Cancer Society, there are currently 2 million breast cancer (BC) survivors in the USA and 20% of them cope with lymphedema (LE). The primary aim of this study was to determine the predictive factors of BC-related LE. The secondary aim was to investigate the impact of predictors on the severity of LE. The study design was intended to be a 1:2 matched case-control study. Instead, we stratified on age (+/-10 years), radiation therapy (y/n), and type of operation (SM/MRM/MRM with tram). Patients who underwent BC surgery between 1990 and 2000 at UPMC Magee-Womens Hospital were reviewed for LE. Data were collected on 52 women with LE and 104 female controls. Logistic regression was utilized to assess the relationship between risk factors and LE. Ordinal logistic regression was performed to determine the association between risk factors and severity of LE. Severity was defined according to the volume difference between affected and unaffected limbs. Risk factors considered were occupation/hobby (hand use), TNM stage, number of dissected nodes, number of positive nodes, tumor size, infection, allergy, diabetes mellitus, hypertension, hypothyroidism, chronic obstructive pulmonary disease, and body mass index (BMI). LE was mild in 43 patients and was moderate/severe in nine patients. The level of hand use in the control group was categorized as low in 56 (54%), medium in 15 (14%), and high in 33 (32%) patients. The corresponding frequencies were 14 (33%), 6 (14%) and 23 (53%) for patients with mild LE and 3 (33%), 1 (11%), 5 (56%) for patients with moderate/severe LE (p < 0.05). Infection of the operated side arm was reported by two (2%) patients in the control group, 14 (33%) patients with mild LE and five (56%) patients with moderate/severe LE (p < 0.05). The mean BMI was 26.1 kg/m(2) (SD 4.9) for the control group, 29.0 kg/m(2) (SD 5.9) for the mild LE group and 30.9 kg/m(2) (SD 7.5) for patients with moderate/severe LE (p < 0.05). The results of this stratified case-control study demonstrated that the risk and severity of LE was statistically related to infection, BMI, and level of hand use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Soran</LastName><ForeName>Atilla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Magee-Womens Hospital, Pittsburgh, Pennsylvania 15213, USA. asoran@magee.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Angelo</LastName><ForeName>Gina</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Begovic</LastName><ForeName>Mirsada</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ardic</LastName><ForeName>Figen</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Harlak</LastName><ForeName>Ali</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Samuel Wieand</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Vogel</LastName><ForeName>Victor G</ForeName><Initials>VG</Initials></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Ronald R</ForeName><Initials>RR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Breast J</MedlineTA><NlmUniqueID>9505539</NlmUniqueID><ISSNLinking>1075-122X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>1</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>3</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>1</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17238983</ArticleId><ArticleId IdType="pii">TBJ342</ArticleId><ArticleId IdType="doi">10.1111/j.1524-4741.2006.00342.x</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003776 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003776 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:17238983
|texte= Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:17238983" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |